Iron sucrose injection

A sterile aqueous complex of polynuclear iron (III)-hydroxide in sucrose for intravenous use.
Following intravenous administration, iron sucrose is dissociated by the reticuloendothelial system into iron and sucrose; the sucrose component is eliminated mainly by urinary excretion.
Iron sucrose can be administered with or without erythropoietin to raise hemoglobin levels, and may be used in cases of oral iron therapy intolerance or ineffectiveness.
Hypersensitivity reactions are less common with iron sucrose compared to other parenteral iron products, such as iron dextran.

​Disclaimer. Pallipedia does not endorse or recommend any commercial products, processes, or services; therefore, their mention cannot be construed as such. Pallipedia should not be used as guidance to treatment and its purpose is to provide users with information to help them better understand conditions and the current range of approaches related to palliative care. Pallipedia urges health care providers and patients to always consult other relevant and up-to-date experts.